|
시장보고서
상품코드
2076101
장기 이식용 면역억제제 시장 : 약제 클래스별, 이식 유형별, 유통 채널별, 지역별Organ Transplant Immunosuppressant Drugs Market, By Drug Class, By Transplant Type, By Distribution Channel, By geography |
||||||
가격
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
장기 이식용 면역억제제 시장은 2026년에 56억 8,000만 달러 규모에 이를 것으로 추정되고 있어 2033년까지 71억 3,000만 달러에 이를 것으로 예상되고 있습니다. 2026년부터 2033년까지 CAGR 3.3%로 성장할 전망입니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도 : | 2025년 | 2026년 시장 규모 : | 56억 8,000만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 2026-2033년 예측 기간 CAGR : | 3.30% | 2033년 시장 규모 예측 : | 71억 3,000만 달러 |
장기 이식이 성공한 후, 면역억제제를 복용해야 하는 경우가 있습니다. 이러한 약물은 면역 체계가 이식된 새로운 장기를 공격(거부)하는 것을 막는 역할을 합니다. 일반적으로 이러한 약물은 평생 동안, 혹은 치료가 끝날 때까지 복용해야 합니다. 경구 투여 또는 정맥 주사를 통해, 이러한 약물은 체내의 면역 세포가 이식된 장기를 더 이상 공격하지 못하도록 막음으로써 작용합니다. 또한, 이식된 장기에 대한 알레르기 반응을 억제하고, 이식 조직 주변의 염증을 완화하는 작용도 있습니다.
시장 역학:
예측 기간 동안 신약의 승인 및 출시가 전 세계 장기 이식용 면역억제제 시장의 성장을 견인할 것으로 예측됩니다. 예를 들어, 2021년 7월, Kadmon Holdings, Inc.는 만성 이식편대숙주병(GVHD)을 앓는 성인 및 소아 환자를 위한 치료제로 REZUROCK(벨모스딜)에 대해 미국 식품의약국(FDA)의 승인을 획득했습니다.
임상시험에서 나온 부정적인 결과는 전 세계 장기 이식용 면역억제제 시장의 성장을 저해할 것으로 예측됩니다. 예를 들어, 2021년 9월, 노바티스 AG는 신장 이식 환자를 대상으로 한 데이터의 초기 분석 결과, 임상시험 중인 치료법이 표준 치료에 비해 효능이 낮은 것으로 밝혀짐에 따라, 장기 거부 반응을 예방하기 위한 약물의 중기 임상시험을 중단한다고 발표했습니다.
이 시장에서는 몇 가지 M&A 활동이 관찰됩니다. 예를 들어, 2021년 9월, 사노피는 미국에 본사를 둔 바이오의약품 기업인 카도몬 홀딩스의 인수를 발표했습니다.
본 조사의 주요 특징:
- 본 조사에서는 다양한 부문의 잠재적 수익 기회를 파악하고, 이 시장에서 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한, 본 조사에서는 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 그리고 주요 기업들이 채택하고 있는 경쟁 전략에 관한 중요한 인사이트도 제공합니다.
- 본 조사에서는 다음의 매개변수(기업 개요, 제품 포트폴리오, 주요 하이라이트, 재무 실적, 전략)를 바탕으로 전 세계 장기 이식용 면역억제제 시장의 주요 기업 프로파일을 소개했습니다.
- 이 보고서를 통해 얻은 인사이트를 바탕으로, 기업의 마케팅 담당자 및 경영진은 향후 제품 출시, 제품 유형 업그레이드, 시장 확대 및 마케팅 전략에 대해 정보에 입각한 의사결정을 내릴 수 있게 됩니다.
- 이 세계 장기 이식용 면역억제제 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진출기업, 금융 애널리스트 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 전 세계 장기 이식용 면역억제제 시장 분석에 활용되는 다양한 전략 매트릭스를 활용함으로써 의사결정을 원활하게 진행할 수 있을 것입니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
제3장 시장 역학, 규제 및 동향 분석
제4장 세계의 장기 이식용 면역억제제 시장 : 약제 클래스별, 2021-2033년
제5장 세계의 장기 이식용 면역억제제 시장 : 이식 유형별, 2021-2033년
제6장 세계의 장기 이식용 면역억제제 시장 : 유통 채널별, 2021-2033년
제7장 세계의 장기 이식용 면역억제제 시장 : 지역별, 2021-2033년
제8장 경쟁 구도
제9장 섹션
JHS 26.07.09Organ Transplant Immunosuppressant Drugs Market is estimated to be valued at USD 5.68 Bn in 2026 and is expected to reach USD 7.13 Bn by 2033, growing at a compound annual growth rate (CAGR) of 3.3% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 5.68 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 3.30% | 2033 Value Projection: | USD 7.13 Bn |
After a successful organ transplant, you may have to take immunosuppressant drugs. These drugs help your immune system from attacking (rejecting) the new organ from which it has been transplanted. In general, they should be taken for your lifetime, or until the treatments are complete. Orally, or injected into a vein, these drugs work by stopping your body's immune cells from further attacking your transplanted organ. They also control your allergic reactions to the transplanted organ and reduce inflammation around the transplanted tissues.
Market Dynamics:
Approval and launch of new drugs is expected to propel growth of the global organ transplant immunosuppressant drugs market over the forecast period. For instance, in July 2021, Kadmon Holdings, Inc. received the U.S. Food and Drug Administration approval for REZUROCK (belumosudil) for the treatment of adult and pediatric patients with chronic graft-versus-host disease.
Negative outcomes in clinical trials is expected to hinder growth of the global organ transplant immunosuppressant drugs market. For instance, in September 2021, Novartis AG announced to halt a mid-stage clinical trial of drug intended to prevent organ rejection after an early look at data in kidney transplant patients showed the experimental treatment was less effective compared to the standard of care therapy.
The market is witnessing several M&A activities. For instance, in September 2021, Sanofi announced to acquire Kadmon Holdings, a U.S.-based biopharmaceutical company.
Key features of the study:
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global organ transplant immunosuppressant drugs market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Astellas Pharma, Genzyme Corporation, Accord Healthcare Ltd., Watson Pharmaceuticals, Inc., Novartis AG, Mylan Laboratories, Inc., GlaxoSmithKline plc., Belcher Pharmaceuticals LLC, Leo Pharma As, Glenmark Pharmaceuticals Ltd., TFF Pharmaceuticals, Inc., TolerogenixX GmbH, Veloxis Pharmaceuticals Inc., Dr. Reddy's Laboratories Ltd., Panacea Biotec Ltd., Strides Pharma Global Pte Ltd., and Hoffman La Roche Ltd.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global organ transplant immunosuppressant drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global organ transplant immunosuppressant drugs market
Detailed Segmentation:
- Global Organ Transplant Immunosuppressant Drugs Market, By Drug Class (Revenue, USD Bn, 2021 - 2033)
- Calcineurin Inhibitors
- Antiproliferative Agents
- mTOR Inhibitor
- Steroids
- Antibodies
- Global Organ Transplant Immunosuppressant Drugs Market, By Transplant Type (Revenue, USD Bn, 2021 - 2033)
- Kidney
- Liver
- Heart
- Lung
- Pancreas
- Others
- Global Organ Transplant Immunosuppressant Drugs Market, By Distribution Channel (Revenue, USD Bn, 2021 - 2033)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Global Organ Transplant Immunosuppressant Drugs Market, By Region (Revenue, USD Bn, 2021 - 2033)
- North America
- North America Organ Transplant Immunosuppressant Drugs Market , By Drug Class:
- Calcineurin Inhibitors
- Antiproliferative Agents
- mTOR Inhibitor
- Steroids
- Antibodies
- North America Organ Transplant Immunosuppressant Drugs Market , By Transplant Type:
- Kidney
- Liver
- Heart
- Lung
- Pancreas
- Others
- North America Organ Transplant Immunosuppressant Drugs Market , By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- North America Organ Transplant Immunosuppressant Drugs Market , By Drug Class:
- North America Organ Transplant Immunosuppressant Drugs Market , By Country (Revenue, USD Bn, 2021 - 2033)
- U.S.
- Canada
- Latin America
- Latin America Organ Transplant Immunosuppressant Drugs Market , By Drug Class:
- Calcineurin Inhibitors
- Antiproliferative Agents
- mTOR Inhibitor
- Steroids
- Antibodies
- Latin America Organ Transplant Immunosuppressant Drugs Market , By Transplant Type:
- Kidney
- Liver
- Heart
- Lung
- Pancreas
- Others
- Latin America Organ Transplant Immunosuppressant Drugs Market , By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Latin America Organ Transplant Immunosuppressant Drugs Market , By Country:
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Latin America Organ Transplant Immunosuppressant Drugs Market , By Drug Class:
- Europe
- Europe Organ Transplant Immunosuppressant Drugs Market , By Drug Class:
- Calcineurin Inhibitors
- Antiproliferative Agents
- mTOR Inhibitor
- Steroids
- Antibodies
- Europe Organ Transplant Immunosuppressant Drugs Market , By Transplant Type:
- Kidney
- Liver
- Heart
- Lung
- Pancreas
- Others
- Europe Organ Transplant Immunosuppressant Drugs Market , By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Europe Organ Transplant Immunosuppressant Drugs Market , By Country:
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Europe Organ Transplant Immunosuppressant Drugs Market , By Drug Class:
- Asia Pacific
- Asia Pacific Organ Transplant Immunosuppressant Drugs Market, By Drug Class:
- Calcineurin Inhibitors
- Antiproliferative Agents
- mTOR Inhibitor
- Steroids
- Antibodies
- Asia Pacific Organ Transplant Immunosuppressant Drugs Market , By Transplant Type:
- Kidney
- Liver
- Heart
- Lung
- Pancreas
- Others
- Asia Pacific Organ Transplant Immunosuppressant Drugs Market , By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Asia Pacific Organ Transplant Immunosuppressant Drugs Market , By Country:
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Asia Pacific Organ Transplant Immunosuppressant Drugs Market, By Drug Class:
- Middle East
- Middle East Organ Transplant Immunosuppressant Drugs Market, By Drug Class:
- Calcineurin Inhibitors
- Antiproliferative Agents
- mTOR Inhibitor
- Steroids
- Antibodies
- Middle East Organ Transplant Immunosuppressant Drugs Market, By Transplant Type:
- Kidney
- Liver
- Heart
- Lung
- Pancreas
- Others
- Middle East Organ Transplant Immunosuppressant Drugs Market , By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Middle East Organ Transplant Immunosuppressant Drugs Market, By Country:
- GCC
- Israel
- Rest of Middle East
- Middle East Organ Transplant Immunosuppressant Drugs Market, By Drug Class:
- Africa
- Africa Organ Transplant Immunosuppressant Drugs Market, By Drug Class:
- Calcineurin Inhibitors
- Antiproliferative Agents
- mTOR Inhibitor
- Steroids
- Antibodies
- Middle East Organ Transplant Immunosuppressant Drugs Market, By Transplant Type:
- Kidney
- Liver
- Heart
- Lung
- Pancreas
- Others
- Middle East Organ Transplant Immunosuppressant Drugs Market, By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Middle East Organ Transplant Immunosuppressant Drugs Market, By Country:
- North Africa
- Central Africa
- South Africa
- Africa Organ Transplant Immunosuppressant Drugs Market, By Drug Class:
- Company Profiles
- Astellas Pharma*
- Company Highlights
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategy
- Genzyme Corporation
- Accord Healthcare Ltd.
- Watson Pharmaceuticals, Inc.
- Novartis AG
- Mylan Laboratories, Inc.
- GlaxoSmithKline plc.
- Belcher Pharmaceuticals LLC
- Leo Pharma AS
- Glenmark Pharmaceuticals Ltd.
- TFF Pharmaceuticals, Inc.
- TolerogenixX GmbH
- Veloxis Pharmaceuticals Inc.
- Reddy's Laboratories Ltd.
- Panacea Biotec Ltd.
- Strides Pharma Global Pte Ltd.
- F-Hoffman La Roche
"*" marked represents similar segmentation in other categories in the respective section.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Drug Class
- Market Snippet, By Transplant Type
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Opportunities
- Recent Trends
- Merger, Acquisition, and Collaborations
- Regulatory Scenario
- Key Developments
- PEST Analysis
- PORTER's Analysis
4. Global Organ Transplant Immunosuppressant Drugs Market, By Drug Class, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Calcineurin Inhibitors
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Segment Trends
- Antiproliferative Agents
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Segment Trends
- mTOR Inhibitor
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Segment Trends
- Steroids
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Segment Trends
- Antibodies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Segment Trends
5. Global Organ Transplant Immunosuppressant Drugs Market, By Transplant Type, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Kidney
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Segment Trends
- Liver
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Segment Trends
- Heart
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Segment Trends
- Lung
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Segment Trends
- Pancreas
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Segment Trends
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Segment Trends
6. Global Organ Transplant Immunosuppressant Drugs Market, By Distribution Channel, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
7. Global Organ Transplant Immunosuppressant Drugs Market, By Region, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- North America
- Market Size and Forecast, Y-o-Y Growth, By Drug Class, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth, By Transplant Type, 2021 -2033, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth, By Distribution Channel, 2021-2033, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth, By Country, 2021 -2033, (US$ Bn)
- U.S.
- Canada
- Europe
- Market Size and Forecast, Y-o-Y Growth, By Drug Class, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth, By Transplant Type, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth, By Country, 2021 - 2033, (US$ Bn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Market Size and Forecast, Y-o-Y Growth, By Drug Class, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth, By Transplant Type, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth, By Country, 2021 - 2033, (US$ Bn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- Market Size and Forecast, Y-o-Y Growth, By Drug Class, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth, By Transplant Type, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth, By Country, 2021 - 2033, (US$ Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East
- Market Size and Forecast, Y-o-Y Growth, By Drug Class, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth, By Transplant Type, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth, By Country, 2021 - 2033, (US$ Bn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, Y-o-Y Growth, By Drug Class, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth, By Transplant Type, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth, By Country, 2021 - 2033, (US$ Bn)
- North Africa
- Central Africa
- South Africa
8. Competitive Landscape
- Company Profiles
- Astellas Pharma
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Genzyme Corporation
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Accord Healthcare Ltd.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Watson Pharmaceuticals, Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Novartis AG
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Mylan Laboratories, Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- GlaxoSmithKline plc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Belcher Pharmaceuticals LLC
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Leo Pharma As
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Glenmark Pharmaceuticals Ltd.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- TFF Pharmaceuticals, Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- TolerogenixX GmbH
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Veloxis Pharmaceuticals Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Dr. Reddy's Laboratories Ltd.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Panacea Biotec Ltd.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Strides Pharma Global Pte Ltd.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Hoffman La Roche
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Astellas Pharma
- Analysts' Views
9. Section
- References
- Research Methodology
- About us and Sales Contact
